Do 'exosomes' (tiny cell-signaling particles, often from stem cells or plants) injected into the scalp actually regrow hair, and is the evidence solid yet?

Exosome injections show early, genuinely promising signals for hair regrowth and appear safe in the studies conducted so far -- but this remains a new, largely unregulated, and unproven treatment, backed by only 2 real randomized trials out of 11 studies; it should be seen as experimental rather than an established option, and treatment costs can be high.

What they did

Systematically reviewed all published clinical studies (not just lab or animal studies) testing exosome-based scalp injections for various types of hair loss, across different exosome sources (adipose tissue, placenta, hair follicles, bone marrow, foreskin, umbilical cord, and plant extracts).

What they found

Across studies, hair density increased by roughly 9.5 to 35 hairs per cm², and hair thickness improved by up to about 13 micrometers. Patient satisfaction was generally high and no serious adverse events were reported; mild, temporary scalp irritation occurred occasionally (in about 20% of patients using one plant-extract-derived product).

Limitations

Very small total evidence base (298 patients across 11 studies, several using weaker study designs like case reports and uncontrolled single-arm trials); large differences in how exosomes were sourced, dosed, and delivered across studies, making direct comparison difficult; most studies lacked a placebo or control group; no regulatory (FDA or equivalent) approval exists for any exosome product for hair loss.

Who paid for it

Authors report no conflicts of interest for the review itself; underlying primary studies had varied, not fully detailed, funding sources

Read the original

Exosomes and Hair Regeneration: A Systematic Review of Clinical Evidence Across Alopecia Types and Exosome Sources ↗ · Al Ameer MA, Alnajim AT, Al Ameer A, Alsalman Z, Al Ameer GA, Alnajim ST, Alghamdi AA, Moideen R, Al Hadi EM · DOI 10.2147/CCID.S543451